000 01167 a2200325 4500
005 20250514014820.0
264 0 _c20020419
008 200204s 0 0 eng d
022 _a1469-493X
024 7 _a10.1002/14651858.CD001330
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSolari, A
245 0 0 _aAminopyridines for symptomatic treatment in multiple sclerosis.
_h[electronic resource]
260 _bThe Cochrane database of systematic reviews
_c2001
300 _aCD001330 p.
_bdigital
500 _aPublication Type: Journal Article; Review; Systematic Review
650 0 4 _a4-Aminopyridine
_xanalogs & derivatives
650 0 4 _aAmifampridine
650 0 4 _aCross-Over Studies
650 0 4 _aHumans
650 0 4 _aMultiple Sclerosis
_xcomplications
650 0 4 _aPotassium Channel Blockers
_xtherapeutic use
650 0 4 _aRandomized Controlled Trials as Topic
700 1 _aUitdehaag, B
700 1 _aGiuliani, G
700 1 _aPucci, E
700 1 _aTaus, C
773 0 _tThe Cochrane database of systematic reviews
_gno. 4
_gp. CD001330
856 4 0 _uhttps://doi.org/10.1002/14651858.CD001330
_zAvailable from publisher's website
999 _c11603834
_d11603834